More Business Wire
View Older Stories View Newer Stories-
Alliant Insurance Services Adds Strength to Louisiana Brokerage Team, Hires Buzz Mansfield
-
Good Time Brewing Company Expands With Direct-to-Consumer Shipping in Time for Dry January –Storied West Village Bar Owner Embraces N/A Wave–
-
Upfort Named a Winner of the 2023 BIG Awards for Business and Pan Finance Awards 2023
-
Middleburg Communities to Develop Dynamic Build-to-Rent Community in Wilmington, North Carolina
-
MSCI Completes Acquisition of Fabric
-
Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.
-
Scienaptic AI Partners with DigiFi to Provide Advanced Credit Scoring
-
Psychiatry and Neuroscience Expert Dr. Joel Raskin Joins ArrivoBio as Chief Medical Advisor
-
Consolidated Communications Proposed Transaction is Financially Compelling and Delivers Certain Cash Value at a Premium Valuation
-
GrowGeneration to Participate in the 26th Annual ICR Conference
-
Enveric Biosciences Updates Key Data Underpinning Selection of EB-003 as Lead Drug Candidate from EVM301 Series
-
Olympic Steel Names Zachary J. Siegal President of Manufactured Metal Products
-
Soluna’s Project Dorothy Outperforms Traditional Centers with an 18% Lower Carbon Footprint
-
Synchron Appoints Riki Banerjee as Chief Technology Officer
-
Immunome to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
MIPS Welcomes New Executives as Part of Company’s Growth and Expansion
-
Independence Realty Trust Completes Sale of Four Properties, Advancing Portfolio Optimization and Deleveraging Strategy
-
Skyward Specialty chooses Milliman Datalytics-Defense for its AI-enabled legal spend insights
-
ZCG-Backed Twin Star Home Acquires Grand Basket, Strengthening Omnichannel Leadership in Outdoor Products
-
Biomedical Technology Veteran Mike Hess Joins IEEE Pulse as Editor-in-Chief
-
Odyssey Investment Partners Promotes Three Investment Professionals
-
Advancing Medical Nutrition: Hologram Sciences Announces collaboration with Mayo Clinic to Develop Precision Nutrition Platform
-
Jennifer Patterson joins Haug Partners LLP’s Antitrust group
-
Red Robin Gourmet Burgers, Inc. to Participate in Two Investor Conferences in January
-
Berkshire Hathaway Specialty Insurance Enhances Multinational Capabilities
-
ADARx Pharmaceuticals to Present at the J.P. Morgan 42nd Annual Healthcare Conference
-
OcuTerra Therapeutics Announces Last Patient Completes Final Visit in Nesvategrast (OTT166) Eye Drop Phase 2 DR:EAM Clinical Trial in Diabetic Retinopathy
-
Suffolk Adds Experienced Leader William Ellis to Mission Critical Group as Vice President, Business Development to Drive Strategic Growth
-
Energize Marketing Names Melissa Stillwell to Spearhead Customer Success and Operations Department
-
Rapport Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
WNS to Release Fiscal 2024 Third Quarter Financial and Operating Results on January 18, 2024
-
Proxy Advisory Firm Egan-Jones Recommends SomaLogic Shareholders Vote Against Proposed Merger with Standard BioTools
-
Immusoft To Present on ISP-001 Clinical Trial at WORLDSymposium™ 2024 Conference
-
Atlantic Union Bankshares Corporation To Release Fourth Quarter and Full Year 2023 Financial Results
-
Sonendo Partners With BEST for Dentistry to Continue Expanding Access to the Innovative GentleWave® Procedure
-
Ventus Therapeutics Initiates Clinical Testing of VENT-03, a First-in-Class, Orally Administered cGAS Inhibitor
-
Evolv Technology to Present at 26th Annual Needham Growth Conference
-
Intuit TurboTax's 2024 "Make Your Moves Count" Campaign Highlights Its Tax Experts, AI Technology and Filing Solutions Ensuring the Best Tax Outcome for All Types of Filers
-
UnCruise Adventures Launches ‘Leap into Adventure’ WAVE Season Deals
-
Thermo Fisher Scientific to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024
-
ENYO Pharma Announces a €39 Million Series C Financing and FDA Clearance to Advance Vonafexor in a Phase 2 Clinical Trial for Patients With Alport Syndrome
-
EnerSys Announces Proposed Offering of Senior Notes
-
Summit Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
ReCode Therapeutics Doses First Patient in Phase 1 Clinical Study of Novel mRNA-based Therapy for the Treatment of Primary Ciliary Dyskinesia
-
Cathedra Bitcoin Provides Operations Update
-
Areteia Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024
-
SentinelOne® to Expand Cloud Security Capabilities with Acquisition of PingSafe
-
Perion Network Announces Conference Participation in January 2024
-
Melt Pharmaceuticals Provides Corporate Update
-
LumiThera Provides Update on FDA Review of Valeda Treatment for Dry AMD Patients
